Our Product Portfolio

Innovative Diagnostic Solutions for Autoimmune and Infectious Diseases
Medipan GmbH and GA Generic Assays GmbH are leaders in providing innovative in-vitro diagnostic solutions for autoimmune and infectious diseases. We develop and supply high-quality diagnostic products to laboratories, clinics, research centers, and physicians worldwide.
Our portfolio includes manual test kits and automated laboratory systems, all based on advanced immunological techniques such as ELISA, Radioimmunoassay (RIA), and Immunofluorescence Assays (IFA). These technologies enable precise and reliable detection of disease-specific antibodies and biomarkers, supporting accurate diagnosis, patient monitoring, and improved clinical outcomes.
Diagnostics for Multiple Indications
We provide assays for detecting and monitoring autoimmune, inflammatory, and chronic diseases, including thyroid disorders, diabetes, rheumatoid arthritis, gastrointestinal diseases, and neurological conditions. Each team rigorously validates tests to deliver reliable and reproducible results, enabling confident clinical decisions.
Global Presence and Efficient Lab Solutions
Operating in over 70 countries, we provide solutions that enhance workflow efficiency, save time, and ensure consistent results. Our products are designed for accuracy, ease of use, scalability, and seamless integration into daily lab operations, serving labs of all sizes -from small facilities to high-throughput platforms.
Structured Product Portfolio
The product portfolio organizes offerings into Methods, Systems, Indications, and Innovations. This structure helps users quickly find the right solution, from specific immunological techniques and automated testing platforms to targeted assays for particular conditions and the latest laboratory advancements.
Medipan and GA Generic Assays advance precision diagnostics and actively support the global medical community. Their portfolio delivers reliable, state-of-the-art solutions tailored to modern laboratory needs.